C1Q MODULATION OF ANTIBODY DEPENDENT ENHANCEMENT OF DENGUE VIRUS INFECTION IN HUMAN MYELOID CELL LINES IS DEPENDENT ON CELL TYPE AND ANTIBODY SPECIFICITY

Intro: Antibodies play a critical role in protection and pathogenesis of dengue virus (DENV). In the presence of preexisting antibodies that bind but do not neutralize viral particles, virus-antibody immune complexes are internalized by Fcγ receptor (FcγR)-expressing cells, generating increased vira...

Full description

Bibliographic Details
Main Authors: A. Byrne, L. Talarico
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S120197122300437X
_version_ 1797824577242398720
author A. Byrne
L. Talarico
author_facet A. Byrne
L. Talarico
author_sort A. Byrne
collection DOAJ
description Intro: Antibodies play a critical role in protection and pathogenesis of dengue virus (DENV). In the presence of preexisting antibodies that bind but do not neutralize viral particles, virus-antibody immune complexes are internalized by Fcγ receptor (FcγR)-expressing cells, generating increased viral titers and the liberation of pathogenic mediators. The complement protein C1q can bind to immune complexes and reduce the magnitude of antibody-dependent enhancement (ADE). We aimed to investigate the mechanisms of C1q modulation of ADE, focusing on processes of viral entry. Methods: We established a model of C1q modulation of ADE of DENV-1 infection in human cell lines using monoclonal antibodies (anti-flavivirus envelope protein 4G2 and anti-DENV pre-membrane protein 2H2), and physiological concentrations of C1q. We analyzed the mechanism of this modulation using cell-based adsorption and internalization assays and blockade of specific routes of endocytosis with pharmacological inhibitors. Findings: The modulation of ADE of DENV-1 by C1q is dependent on the FcγR and the specificity of the antibody comprising the immune complex. C1q produced a 250- to 23-fold reduction of ADE of DENV-1 in cells that express the low affinity type II FcγR (K562 cells), but not in cells that express the high affinity type I FcγR (U937 cells). C1q reduced entry of immune complexes composed of DENV-1 and 4G2 or 2H2 during adsorption (99% and 90% reduction in viral titer; p=0.015 and p=0.02, respectively), but in the case of immune complexes formed by 2H2, C1q also reduced ADE during internalization of immune complexes (82% reduction, p=0.02). The mechanism of C1q modulation of ADE corresponded to the participation of different components of endocytic pathways. Conclusion: The study of virus-host interactions that drive protective immunity, and the immunological mechanisms that regulate the balance between protection and pathogenesis mediated by the humoral immune response in DENV infections, are key for effective antiviral and vaccine design.
first_indexed 2024-03-13T10:40:05Z
format Article
id doaj.art-72517ece1c154998934ec53f9d723a09
institution Directory Open Access Journal
issn 1201-9712
language English
last_indexed 2024-03-13T10:40:05Z
publishDate 2023-05-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj.art-72517ece1c154998934ec53f9d723a092023-05-18T04:38:58ZengElsevierInternational Journal of Infectious Diseases1201-97122023-05-01130S124S125C1Q MODULATION OF ANTIBODY DEPENDENT ENHANCEMENT OF DENGUE VIRUS INFECTION IN HUMAN MYELOID CELL LINES IS DEPENDENT ON CELL TYPE AND ANTIBODY SPECIFICITYA. Byrne0L. Talarico1Hospital de Niños Ricardo Gutierrez, Laboratory of Infectious Diseases and Molecular Biology, Department of Medicine, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET, Buenos Aires, ArgentinaHospital de Niños Ricardo Gutierrez, Laboratory of Infectious Diseases and Molecular Biology, Department of Medicine, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET, Buenos Aires, ArgentinaIntro: Antibodies play a critical role in protection and pathogenesis of dengue virus (DENV). In the presence of preexisting antibodies that bind but do not neutralize viral particles, virus-antibody immune complexes are internalized by Fcγ receptor (FcγR)-expressing cells, generating increased viral titers and the liberation of pathogenic mediators. The complement protein C1q can bind to immune complexes and reduce the magnitude of antibody-dependent enhancement (ADE). We aimed to investigate the mechanisms of C1q modulation of ADE, focusing on processes of viral entry. Methods: We established a model of C1q modulation of ADE of DENV-1 infection in human cell lines using monoclonal antibodies (anti-flavivirus envelope protein 4G2 and anti-DENV pre-membrane protein 2H2), and physiological concentrations of C1q. We analyzed the mechanism of this modulation using cell-based adsorption and internalization assays and blockade of specific routes of endocytosis with pharmacological inhibitors. Findings: The modulation of ADE of DENV-1 by C1q is dependent on the FcγR and the specificity of the antibody comprising the immune complex. C1q produced a 250- to 23-fold reduction of ADE of DENV-1 in cells that express the low affinity type II FcγR (K562 cells), but not in cells that express the high affinity type I FcγR (U937 cells). C1q reduced entry of immune complexes composed of DENV-1 and 4G2 or 2H2 during adsorption (99% and 90% reduction in viral titer; p=0.015 and p=0.02, respectively), but in the case of immune complexes formed by 2H2, C1q also reduced ADE during internalization of immune complexes (82% reduction, p=0.02). The mechanism of C1q modulation of ADE corresponded to the participation of different components of endocytic pathways. Conclusion: The study of virus-host interactions that drive protective immunity, and the immunological mechanisms that regulate the balance between protection and pathogenesis mediated by the humoral immune response in DENV infections, are key for effective antiviral and vaccine design.http://www.sciencedirect.com/science/article/pii/S120197122300437X
spellingShingle A. Byrne
L. Talarico
C1Q MODULATION OF ANTIBODY DEPENDENT ENHANCEMENT OF DENGUE VIRUS INFECTION IN HUMAN MYELOID CELL LINES IS DEPENDENT ON CELL TYPE AND ANTIBODY SPECIFICITY
International Journal of Infectious Diseases
title C1Q MODULATION OF ANTIBODY DEPENDENT ENHANCEMENT OF DENGUE VIRUS INFECTION IN HUMAN MYELOID CELL LINES IS DEPENDENT ON CELL TYPE AND ANTIBODY SPECIFICITY
title_full C1Q MODULATION OF ANTIBODY DEPENDENT ENHANCEMENT OF DENGUE VIRUS INFECTION IN HUMAN MYELOID CELL LINES IS DEPENDENT ON CELL TYPE AND ANTIBODY SPECIFICITY
title_fullStr C1Q MODULATION OF ANTIBODY DEPENDENT ENHANCEMENT OF DENGUE VIRUS INFECTION IN HUMAN MYELOID CELL LINES IS DEPENDENT ON CELL TYPE AND ANTIBODY SPECIFICITY
title_full_unstemmed C1Q MODULATION OF ANTIBODY DEPENDENT ENHANCEMENT OF DENGUE VIRUS INFECTION IN HUMAN MYELOID CELL LINES IS DEPENDENT ON CELL TYPE AND ANTIBODY SPECIFICITY
title_short C1Q MODULATION OF ANTIBODY DEPENDENT ENHANCEMENT OF DENGUE VIRUS INFECTION IN HUMAN MYELOID CELL LINES IS DEPENDENT ON CELL TYPE AND ANTIBODY SPECIFICITY
title_sort c1q modulation of antibody dependent enhancement of dengue virus infection in human myeloid cell lines is dependent on cell type and antibody specificity
url http://www.sciencedirect.com/science/article/pii/S120197122300437X
work_keys_str_mv AT abyrne c1qmodulationofantibodydependentenhancementofdenguevirusinfectioninhumanmyeloidcelllinesisdependentoncelltypeandantibodyspecificity
AT ltalarico c1qmodulationofantibodydependentenhancementofdenguevirusinfectioninhumanmyeloidcelllinesisdependentoncelltypeandantibodyspecificity